Beam Therapeutics Inc. (BEAM) Ownership

$27.09

$1.82 (-6.3%)
Last update: 04:00 PM EST
Day's range
$27
Day's range
$28.87

Beam Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2025 11.69 M $283.79 M   -9.79% 11.46%
ARK INVESTMENT MANAGEMENT LLC 11/12/2025 11.04 M $267.91 M   24.76% 10.82%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 10.06 M $244.23 M   0.50% 9.87%
VANGUARD GROUP INC 11/07/2025 9.25 M $224.52 M   -4.69% 9.07%
BLACKROCK, INC. 11/12/2025 8.15 M $197.76 M   1.82% 7.99%
SUMITOMO MITSUI TRUST HOLDINGS, INC. 10/27/2025 4.83 M $117.24 M   2.14% 4.74%
NIKKO ASSET MANAGEMENT AMERICAS, INC. 11/12/2025 4.83 M $117.24 M   2.20% 4.74%
ARCH VENTURE MANAGEMENT, LLC 11/14/2025 4.54 M $110.19 M   0.00% 4.45%
STATE STREET CORP 11/14/2025 4.01 M $97.29 M   10.18% 3.93%
BELLEVUE GROUP AG 11/14/2025 2.89 M $70.12 M   0.00% 2.83%
KYNAM CAPITAL MANAGEMENT, LP 11/14/2025 2.52 M $61.10 M   4.14% 2.47%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 2.39 M $58.04 M   6.06% 2.34%
MWG MANAGEMENT LTD. 11/12/2025 2.27 M $55.02 M   0.00% 2.22%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 2.26 M $54.93 M   -7.36% 2.22%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 1.72 M $41.75 M   -2.18% 1.69%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 1.67 M $40.42 M   237.53% 1.63%
CASDIN CAPITAL, LLC 11/14/2025 1.60 M $38.83 M   10.34% 1.57%
CONTRARIUS GROUP HOLDINGS LTD 11/12/2025 1.53 M $37.21 M   100.00% 1.50%
REDMILE GROUP, LLC 11/14/2025 1.39 M $33.68 M   -2.52% 1.36%
GOLDMAN SACHS GROUP INC 11/14/2025 1.32 M $32.00 M   2.77% 1.29%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2025 1.26 M $30.58 M   11.33% 1.24%
UBS GROUP AG 11/13/2025 1.14 M $27.61 M   -2.26% 1.12%
NORTHERN TRUST CORP 11/14/2025 854.34 K $20.73 M   3.12% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 841.21 K $20.42 M   8.56% 0.82%
BANK OF AMERICA CORP /DE/ 11/14/2025 779.02 K $18.91 M   -8.49% 0.76%
MORGAN STANLEY 11/14/2025 644.76 K $15.65 M   -50.67% 0.63%
WOODLINE PARTNERS LP 11/14/2025 546.56 K $13.26 M   -28.23% 0.54%
JPMORGAN CHASE & CO 11/26/2025 541.30 K $13.14 M   -6.72% 0.53%
ROYAL BANK OF CANADA 11/14/2025 416.26 K $10.10 M   -25.41% 0.41%
BANK OF NEW YORK MELLON CORP 11/03/2025 409.44 K $9.94 M   27.51% 0.40%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 11/14/2025 400.00 K $9.71 M   -20.00% 0.39%
IQ EQ FUND MANAGEMENT (IRELAND) LTD 11/05/2025 383.53 K $9.31 M   96.39% 0.38%
TWO SIGMA INVESTMENTS, LP 11/14/2025 379.04 K $9.20 M   -32.50% 0.37%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 337.51 K $8.08 M   5.58% 0.33%
TWO SIGMA ADVISERS, LP 11/14/2025 333.00 K $8.08 M   -39.79% 0.33%
ALPHABET INC. 11/07/2025 321.60 K $7.81 M   0.00% 0.32%
BARCLAYS PLC 11/12/2025 313.63 K $7.61 M   -54.19% 0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 299.80 K $7.28 M   43.24% 0.29%
BAILLIE GIFFORD & CO 10/31/2025 297.80 K $7.23 M   -0.78% 0.29%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 296.09 K $7.19 M   29.37% 0.29%
PEREGRINE INVESTMENT MANAGEMENT INC 11/06/2025 267.93 K $6.50 M   1.39% 0.26%
CITADEL ADVISORS LLC 11/14/2025 261.90 K $6.36 M   33.62% 0.26%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 255.00 K $6.19 M   24.39% 0.25%
NUVEEN, LLC 11/12/2025 237.34 K $5.76 M   2.35% 0.23%
INVESCO LTD. 11/13/2025 176.86 K $4.29 M   37.24% 0.17%
SWISS NATIONAL BANK 11/13/2025 175.40 K $4.26 M   1.62% 0.17%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 175.00 K $4.25 M   100.00% 0.17%
CAPTION MANAGEMENT, LLC 11/14/2025 170.00 K $4.13 M   -69.21% 0.17%
VESTMARK ADVISORY SOLUTIONS, INC. 11/10/2025 166.30 K $4.04 M   -48.51% 0.16%
HRT FINANCIAL LP 11/14/2025 162.71 K $3.95 M   100.00% 0.16%

Beam Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 287 institutional investors and hedge funds held shares of Beam Therapeutics Inc.. The most heavily invested institutionals were:

FMR LLC: 11.69 M

ARK Investment Management LLC: 11.04 M

FARALLON CAPITAL MANAGEMENT LLC: 10.06 M

VANGUARD GROUP INC: 9.25 M

BlackRock, Inc.: 8.15 M

Sumitomo Mitsui Trust Holdings, Inc.: 4.83 M

104.49% of Beam Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 115.70 M shares in the last 24 months. This purchase volume represents approximately $3.13 B in transactions.